| Cytokines |
|
|
| IL-6 |
Mild/moderate decrease/no effect |
Nurieva et al., 2008; Poholek et al., 2010; Eto et al., 2011; Harker et al., 2011
|
| IL-21, IL-21R |
Mild/moderate decrease/no effect |
Vogelzang et al., 2008; Linterman et al., 2010; Poholek et al., 2010; Eto et al., 2011
|
| IL-27Ra |
Decreased |
Batten et al., 2010 |
| Signaling |
|
|
|
SH2D1A (SAP)a
|
Absent |
Qi et al., 2008; Linterman et al., 2009; Cannons et al., 2010; Deenick et al., 2010
|
| STAT3a
|
Decreased |
Nurieva et al., 2008; Lu et al., 2011
|
| STAT5 |
Increased |
Johnston et al., 2012 |
| Transcription factors |
|
|
| Bcl-6 |
Absent |
Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009; Poholek et al., 2010
|
| c-Maf |
Decreased |
Bauquet et al., 2009; Pot et al., 2009; Hiramatsu et al., 2010; Kroenke et al., 2012
|
| BATF |
Absent |
Betz et al., 2010; Ise et al., 2011
|
| IRF4 |
Decreased/absent |
Kwon et al., 2009 |
|
PRDM1 (Blimp1) |
Increased |
Johnston et al., 2009 |
|
Tbx21 (T-bet) |
Increased |
Nakayamada et al., 2011; Oestreich et al., 2012
|
| Surface receptors |
|
|
| CD40/CD40La
|
Decreased/absent |
Akiba et al., 2005; Bossaller et al., 2006
|
| ICOSa/ICOS-L |
Decreased/absent |
| CD28 |
Decreased/absent |
Akiba et al., 2005; Salek-Ardakani et al., 2011
|
| CD80 |
No effect |
| CD86 |
Decreased |
|
| CD84 |
Decreased |
Cannons et al., 2010 |